Average Co-Inventor Count = 5.04
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ambrx, Inc. (11 from 113 patents)
2. Amylin Pharmaceuticals, Inc. (2 from 164 patents)
3. Astrazeneca Pharmaceuticals LP (2 from 38 patents)
4. Aegerion Pharmaceuticals, Inc. (1 from 4 patents)
5. Amryt Pharmaceuticals Inc. (1 from 3 patents)
6. I2pure Corp. (1 from 2 patents)
7. Trethera Corporation (1 from 1 patent)
17 patents:
1. 11596648 - Emollient topical disinfectants
2. 11535659 - Engineered polypeptides having enhanced duration of action
3. 11446307 - Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof
4. 9879063 - Engineered polypeptides having enhanced duration of action and reduced immunogenicity
5. 9593154 - Engineered polypeptides having enhanced duration of action
6. 9382304 - Engineered polypeptides having enhanced duration of action with reduced immunogenicity
7. 9260472 - Modified human four helical bundle polypeptides and their uses
8. 8906676 - Modified human four helical bundle polypeptides and their uses
9. 8907064 - Modified human four helical bundle polypeptides and their uses
10. 8778880 - Human growth hormone modified at position 35
11. 8178494 - Modified human growth hormone formulations with an increased serum half-life
12. 8163695 - Formulations of human growth hormone comprising a non-naturally encoded amino acid
13. 8143216 - Modified human growth hormone
14. 8093356 - Pegylated human interferon polypeptides
15. 7939496 - Modified human growth horomone polypeptides and their uses